Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Teva
Citi
Daiichi Sankyo
Merck
QuintilesIMS
Boehringer Ingelheim
UBS
Express Scripts

Generated: July 15, 2018

DrugPatentWatch Database Preview

Nadolol - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for nadolol and what is the scope of nadolol freedom to operate?

Nadolol
is the generic ingredient in two branded drugs marketed by Us Worldmeds Llc, Amneal Pharms Co, Aurobindo Pharma Ltd, Invagen Pharms, Ivax Sub Teva Pharms, Lupin Ltd, Mylan, Riconpharma Llc, Sandoz, Teva Pharms, and Zydus Pharms Usa Inc, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for nadolol. Twenty suppliers are listed for this compound.
Pharmacology for nadolol
Medical Subject Heading (MeSH) Categories for nadolol
Synonyms for nadolol
(2R,3S)-5-({3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl}oxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol
(2R,3S)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol
(2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol
2,3-cis-1,2,3,4-Tetrahydro-5-((2-hydroxy-3-tert-butylamino)propoxy)-2,3-naphthalenediol
2,3-Naphthalenediol, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-
2,3-Naphthalenediol, 5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-1,2,3,4-tetrahydro-
200N339
42200-33-9
5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-2,3-naphthalenediol
AB00052338_13
AC1L2151
AC1Q1MO3
AC1Q77IZ
AK116142
AKOS015895037
Alti-Nadolol (TN)
Anabet
Anabet (TN)
API0003480
Apo-Nadol (TN)
AX8143086
BDBM25766
BRD-A87606379-001-03-4
BSPBio_003152
CAS-42200-33-9
CCG-39324
CCRIS 1048
CHEMBL649
cid_39147
Corgard
Corgard (TN)
Corgaretic
Corzide (TN)
CPD000058975
CTK4I5836
D00432
D05SHK
DB01203
DivK1c_000427
DSSTox_CID_3342
DSSTox_GSID_23342
DSSTox_RID_76983
DTXSID3023342
EINECS 255-706-3
EN300-50860
FT-0630624
GTPL554
HMS1570D17
HMS1922O05
HMS2093A15
HMS2233E12
HMS3259C07
HMS501F09
HSDB 6532
IDI1_000427
INV-102
INV102
KB-206505
KBio1_000427
KBio2_002123
KBio2_004691
KBio2_007259
KBio3_002652
KBioGR_000765
KBioSS_002123
LS-94578
MFCD00079476
MLS000028580
MLS001148087
MLS002548875
MolPort-003-666-474
Nadic
Nadolol (JP17/USP/INN)
Nadolol [USAN:BAN:INN:JAN]
Nadolol 1.0 mg/ml in Methanol
Nadolol, analytical standard
Nadolol, European Pharmacopoeia (EP) Reference Standard
Nadolol, United States Pharmacopeia (USP) Reference Standard
Nadololum
Nadololum [INN-Latin]
NC00464
NCGC00016851-01
NCGC00021623-03
NCGC00021623-05
NCGC00089811-02
NINDS_000427
Novo-Nadolol (TN)
NSC-758430
NSC758430
Opera_ID_1099
OR066428
OR269677
Pharmakon1600-01503260
Prestwick_108
Prestwick0_000818
Prestwick1_000818
Prestwick2_000818
RTR-032791
SAM002264627
SAM002548970
SBI-0051806.P002
SC-78480
SCHEMBL4177
SMP1_000203
SMR000058975
Solgol
Solgol (TN)
SPBio_001392
SPBio_002636
Spectrum_001643
SPECTRUM1503260
Spectrum2_001546
Spectrum3_001586
Spectrum4_000193
Spectrum5_001255
SQ 11725
SQ-11725
SQ11725
SR-01000000251
SR-01000000251-2
Tox21_110646
Tox21_110646_1
VA11340
VU0239635-6
VWPOSFSPZNDTMJ-UCWKZMIHSA-N

US Patents and Regulatory Information for nadolol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc NADOLOL nadolol TABLET;ORAL 207761-002 Jul 28, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ivax Sub Teva Pharms NADOLOL nadolol TABLET;ORAL 074229-002 Aug 30, 1996 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Invagen Pharms NADOLOL nadolol TABLET;ORAL 203455-002 Dec 18, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lupin Ltd NADOLOL nadolol TABLET;ORAL 209309-002 Oct 5, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for nadolol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-005 Oct 28, 1986 ➤ Sign Up ➤ Sign Up
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-004 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-004 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
US Department of Justice
Fuji
McKesson
UBS
Chubb
Queensland Health
QuintilesIMS
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.